Automated World Health

NCD190.27

 

HUMAN CHORIONIC GONADOTROPIN

 

Effective Date of this Version

1/1/2003

 

Benefit Category

• Diagnostic Laboratory Tests.

• Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

 

Indications and Limitations of Coverage

 

Indications

• Human Chorionic Gonadotropin (hCG) is useful for monitoring and diagnosis of germ cell neoplasms of the:

o Ovary.

o Testis.

o Mediastinum.

o Retroperitoneum.

o Central nervous system.

o In addition, hCG is useful for monitoring pregnant patients with:

 Vaginal bleeding.

 Hypertension.

 Suspected fetal loss.

 

Limitations

• It is not reasonable and necessary to perform hCG testing more than once per month for diagnostic purposes.

o It may be performed as needed for monitoring of patient progress and treatment.

o Qualitative hCG assays are not appropriate for medically managing patients with known or suspected germ cell neoplasms.

• Note: Scroll down for links to the quarterly Covered Code Lists (including narrative).

 

Cross Reference

• Also see the Medicare Claims Processing Manual, Chapter 120, Clinical Laboratory Services Based on Negotiated Rulemaking.

 

Coverage Transmittal Link

• http://www.cms.gov/transmittals/downloads/R17NCD.pdf

 

Other

Covered Code Lists (including narrative)

• January 2013

October 2012

July 2012

April 2012

January 2012

October 2011

July 2011

April 2011

January 2011

October 2010

July 2010

April 2010

January 2010

October 2009

July 2009

April 2009

January 2009

October 2008

July 2008

April 2007

January 2007

 

Changes to Lab NCD Edit Software

• January 2012

October 2011

January 2011

October 2010

July 2010

October 2009

July 2009

January 2009

October 2008

July 2008

April 2007

January 2007

October 2006

July 2006

April 2006

January 2006

October 2005

July 2005

April 2005

January 2005

October 2004

July 2004

April 2004

January 2004

October 2003

July 2003

April 2003

 

Coding Analyses for Labs (CALs)

• This NCD has been or is currently being reviewed under the National Coverage Determination process. The following are existing associations with CALs, from the Coding Analyses for Labs database.

• Original consideration for Human Chorionic Gonadotropin (Addition of ICD-9-CM Code 158.9, Malignant Neoplasm of Peritoneum, Unspecified) (CAG-00372N)

 

Medicare NCD Link

 

Copyright 2006-2018 Automated Clinical Guidelines, LLC. All rights reserved.